Free Trial

Revvity (RVTY) Competitors

Revvity logo
$90.91 +1.46 (+1.63%)
Closing price 08/15/2025 03:58 PM Eastern
Extended Trading
$90.78 -0.13 (-0.15%)
As of 08/15/2025 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RVTY vs. BRKR, TECH, A, DHR, IQV, MTD, TMO, WAT, KEYS, and VLTO

Should you be buying Revvity stock or one of its competitors? The main competitors of Revvity include Bruker (BRKR), Bio-Techne (TECH), Agilent Technologies (A), Danaher (DHR), IQVIA (IQV), Mettler-Toledo International (MTD), Thermo Fisher Scientific (TMO), Waters (WAT), Keysight Technologies (KEYS), and Veralto (VLTO).

Revvity vs. Its Competitors

Revvity (NYSE:RVTY) and Bruker (NASDAQ:BRKR) are related companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment.

In the previous week, Bruker had 8 more articles in the media than Revvity. MarketBeat recorded 21 mentions for Bruker and 13 mentions for Revvity. Revvity's average media sentiment score of 1.36 beat Bruker's score of 0.36 indicating that Revvity is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Revvity
10 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Bruker
4 Very Positive mention(s)
7 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral

Revvity has higher earnings, but lower revenue than Bruker. Revvity is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revvity$2.76B3.83$270.39M$2.3638.52
Bruker$3.44B1.48$113.10M$0.5264.46

Revvity presently has a consensus price target of $120.07, indicating a potential upside of 32.08%. Bruker has a consensus price target of $51.30, indicating a potential upside of 53.04%. Given Bruker's higher possible upside, analysts plainly believe Bruker is more favorable than Revvity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Revvity
0 Sell rating(s)
4 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.71
Bruker
0 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.45

Revvity pays an annual dividend of $0.28 per share and has a dividend yield of 0.3%. Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.6%. Revvity pays out 11.9% of its earnings in the form of a dividend. Bruker pays out 38.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Revvity has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500. Comparatively, Bruker has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500.

Revvity has a net margin of 10.19% compared to Bruker's net margin of 2.31%. Bruker's return on equity of 17.89% beat Revvity's return on equity.

Company Net Margins Return on Equity Return on Assets
Revvity10.19% 7.66% 4.73%
Bruker 2.31%17.89%5.38%

86.7% of Revvity shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 0.7% of Revvity shares are owned by company insiders. Comparatively, 27.3% of Bruker shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Revvity and Bruker tied by winning 9 of the 18 factors compared between the two stocks.

Get Revvity News Delivered to You Automatically

Sign up to receive the latest news and ratings for RVTY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RVTY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVTY vs. The Competition

MetricRevvityMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$10.38B$7.55B$5.67B$20.96B
Dividend Yield0.31%2.79%3.79%3.58%
P/E Ratio38.5273.3830.5827.94
Price / Sales3.8331.08464.2456.18
Price / Cash10.5125.7937.4023.77
Price / Book1.4017.309.095.26
Net Income$270.39M$243.10M$3.25B$994.11M
7 Day Performance4.56%3.01%7.42%1.79%
1 Month Performance-4.23%1.52%5.50%1.73%
1 Year Performance-24.03%18.72%30.67%13.35%

Revvity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVTY
Revvity
3.4312 of 5 stars
$90.91
+1.6%
$120.07
+32.1%
-24.3%$10.38B$2.76B38.5211,000Positive News
BRKR
Bruker
4.962 of 5 stars
$34.72
-8.6%
$53.10
+52.9%
-47.0%$5.76B$3.37B66.7711,396Dividend Announcement
High Trading Volume
TECH
Bio-Techne
4.9585 of 5 stars
$54.88
0.0%
$69.58
+26.8%
-28.4%$8.60B$1.16B66.933,100Positive News
Dividend Announcement
A
Agilent Technologies
4.8776 of 5 stars
$114.99
+1.3%
$139.77
+21.5%
-14.7%$32.24B$6.51B28.3917,900Positive News
DHR
Danaher
4.7447 of 5 stars
$197.50
+0.2%
$247.61
+25.4%
-21.7%$141.13B$23.88B42.0263,000Positive News
Analyst Revision
IQV
IQVIA
4.9135 of 5 stars
$182.97
+0.3%
$228.62
+24.9%
-20.6%$31.02B$15.41B26.4888,000Positive News
Short Interest ↓
Analyst Revision
MTD
Mettler-Toledo International
3.979 of 5 stars
$1,230.69
+2.8%
$1,300.00
+5.6%
-8.3%$24.88B$3.87B31.1617,300Positive News
Insider Trade
TMO
Thermo Fisher Scientific
4.9529 of 5 stars
$467.41
+0.9%
$593.00
+26.9%
-18.8%$174.79B$42.88B27.03125,000Positive News
Analyst Revision
WAT
Waters
4.7946 of 5 stars
$285.97
-1.5%
$380.40
+33.0%
-14.4%$17.28B$2.96B25.957,600
KEYS
Keysight Technologies
4.2766 of 5 stars
$161.65
+1.9%
$187.50
+16.0%
+23.1%$27.31B$4.98B37.9515,500Positive News
Upcoming Earnings
VLTO
Veralto
2.569 of 5 stars
$106.93
+2.1%
$114.00
+6.6%
-1.7%$25.99B$5.19B28.1617,000Positive News

Related Companies and Tools


This page (NYSE:RVTY) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners